| For: | Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World J Cardiol 2014; 6(7): 517-530 [PMID: 25068013 DOI: 10.4330/wjc.v6.i7.517] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i7/517.htm |
| Number | Citing Articles |
| 1 |
Prajakta Vilas Jagdale, Omkar Baban Thore, Shivam Kondiram Bhite, Ashika Ashok Shriyan, Suvarna Pramod Ingale, Divya Ashok Kulkarni, Rajesh Surendra Badani. Prescribing Pattern and Effectiveness of Antihypertensives in Patients Suffering from Hypertension to Diabetes Mellitus with and without Compelling Indications in Tertiary Care Hospital. Journal of The Association of Physicians of India 2024; 72(11) doi: 10.59556/japi.72.0726
|
| 2 |
Esther Oluwasola Aluko, Victor Udo Nna, Adesoji Adedipe Fasanmade. Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats. Archives of Physiology and Biochemistry 2022; 128(6) doi: 10.1080/13813455.2020.1780263
|
| 3 |
Md Yousof Ali, Sumera Zaib, Susoma Jannat, Imtiaz Khan. Inhibition of Angiotensin-I Converting Enzyme by Ginsenosides: Structure–Activity Relationships and Inhibitory Mechanism. Journal of Agricultural and Food Chemistry 2021; 69(21) doi: 10.1021/acs.jafc.1c01231
|
| 4 |
Eren Ogut. Can excessive perspiration contribute to the development of skin tags? A review of the underlying mechanisms and clinical implications. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00128-1
|
| 5 |
Elisabeta Badila, Cristina Japie, Ana-Maria Vrabie, Adrian Badila, Adriana Georgescu. Cardiovascular Disease as a Consequence or a Cause of Cancer: Potential Role of Extracellular Vesicles. Biomolecules 2023; 13(2) doi: 10.3390/biom13020321
|
| 6 |
Simona Frontoni, Fabiana Picconi. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Endocrinology 2018; doi: 10.1007/978-3-319-27316-7_19-1
|
| 7 |
Niki Katsiki, Manfredi Rizzo, Dimitri P. Mikhailidis, Christos S. Mantzoros. New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby!. Metabolism 2015; 64(4) doi: 10.1016/j.metabol.2014.11.001
|
| 8 |
Dongwon Yi, Yang Ho Kang. Drug-Induced Diabetes Mellitus. The Journal of Korean Diabetes 2017; 18(3) doi: 10.4093/jkd.2017.18.3.160
|
| 9 |
Yinghui Wang, Yonggang Wang, Xiaorong Han, Jian Sun, Cheng Li, Binay Kumar Adhikari, Jin Zhang, Xiao Miao, Zhaoyang Chen. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.727487
|
| 10 |
Railda Alcantara Silva, JéssiIyca Borges de Aquino, Ludmylla Borges Gonçalves . TOXICIDADE DOS BETABLOQUEADORES NA TERAPIA ANTI-HIPERTENSIVA: UM ESTUDO SOBRE EFEITOS CUMULATIVOS. Revista Multidisciplinar do Nordeste Mineiro 2025; 19(02) doi: 10.61164/551g6k68
|
| 11 |
Huanhuan Hu, Ai Hori, Chihiro Nishiura, Naoko Sasaki, Hiroko Okazaki, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Kentaro Tomita, Toshiaki Miyamoto, Satsue Nagahama, Akihiko Uehara, Makoto Yamamoto, Taizo Murakami, Chii Shimizu, Makiko Shimizu, Masafumi Eguchi, Takeshi Kochi, Teppei Imai, Akiko Okino, Keisuke Kuwahara, Ikuko Kashino, Shamima Akter, Kayo Kurotani, Akiko Nanri, Isamu Kabe, Tetsuya Mizoue, Naoki Kunugita, Seitaro Dohi, Massimo Pietropaolo. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0159071
|
| 12 |
Francisco J. Tinahones, Baptist Gallwitz, Matias Nordaby, Sophia Götz, Mario Maldonado‐Lutomirsky, Hans J. Woerle, Uli C. Broedl. Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: Two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials. Diabetes, Obesity and Metabolism 2017; 19(2) doi: 10.1111/dom.12814
|
| 13 |
Jia Yao, Xiayu Gong, Xiaoyan Shi, Simin Fan, Junmin Chen, Qiu Chen. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients. Medicine 2020; 99(24) doi: 10.1097/MD.0000000000020674
|
| 14 |
Diana Jiménez-Rodríguez, Manuela Conesa-Garcerán, Teresa Belmonte-García. Evaluation of the effect of relaxation therapy in patients with arterial hypertension. Enfermería Clínica (English Edition) 2019; 29(3) doi: 10.1016/j.enfcle.2018.10.002
|
| 15 |
Gang Xiao, Min Fan, Kui Wang, Haonan Li, Yazhao Shen, Xufeng Cai, Haiyan Jiang, Guangling Wei, Haiyan Yang. Effects of antihypertensives on the degradation behavior of AZ31 alloy in in-vitro environment. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-24906-8
|
| 16 |
Paul Valensi, Selim Jambart. MARRIAGE: A Randomized Trial of Moxonidine Versus Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters. Journal of Cardiovascular Pharmacology and Therapeutics 2024; 29 doi: 10.1177/10742484241258381
|
| 17 |
Thiruvinvamalai S. Dharmarajan, Lekshmi Dharmarajan. Tolerability of Antihypertensive Medications in Older Adults. Drugs & Aging 2015; 32(10) doi: 10.1007/s40266-015-0296-3
|
| 18 |
Mohamed A. Morsy, Gehan H. Heeba, Magda E. Mahmoud. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats. European Journal of Pharmacology 2015; 750 doi: 10.1016/j.ejphar.2015.01.027
|
| 19 |
L.V. Zhuravlyova, T.A. Rohachova , N.V. Sokolnikova , O.O. Yankevich . Insulin resistance and cardiovascular diseases: focus on common in pathogenesis and treatment.. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2023; 2023(2) doi: 10.15407/internalmed2023.02.046
|
| 20 |
Maria Marketou, Yashaswi Gupta, Shashank Jain, Panos Vardas. Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol. Current Hypertension Reports 2017; 19(3) doi: 10.1007/s11906-017-0716-3
|
| 21 |
Catarina Santos, Rui Carvalho, Ana Mafalda Fonseca, Miguel Castelo Branco, Marco Alves, Ivana Jarak. Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063416
|
| 22 |
|
| 23 |
Maria Alessandra Gammone, Konstantinos Efthymakis, Nicolantonio D’Orazio, Eric Gumpricht. Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen. Journal of Nutrition and Metabolism 2021; 2021 doi: 10.1155/2021/5767306
|
| 24 |
I. V. Kim, E. V. Bochkareva, Yu. Ya. Varakin. Cerebrovascular disease screening in general medical practice: methodological aspects. Profilakticheskaya meditsina 2017; 20(5) doi: 10.17116/profmed201720559-64
|
| 25 |
Zhe Li, Hongxia Wei, Ru Li, Baofeng Wu, Ming Xu, Xifeng Yang, Yi Zhang, Yunfeng Liu. The effects of antihypertensive drugs on glucose metabolism. Diabetes, Obesity and Metabolism 2024; 26(11) doi: 10.1111/dom.15821
|
| 26 |
Francine K. Welty, Abdulhamied Alfaddagh, Tarec K. Elajami. Targeting inflammation in metabolic syndrome. Translational Research 2016; 167(1) doi: 10.1016/j.trsl.2015.06.017
|
| 27 |
Manal M. Alem. Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study. Heliyon 2022; 8(11) doi: 10.1016/j.heliyon.2022.e11549
|
| 28 |
Ti Yin, Shu-Chen Kuo, Yea-Yuan Chang, Yung-Tai Chen, Kai-Wei Katherine Wang. Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2017; 102(7) doi: 10.1210/jc.2016-3778
|
| 29 |
Wynne Widiarti, Pandit Bagus Tri Saputra, Cornelia Ghea Savitri, Johanes Nugroho Eko Putranto, Firas Farisi Alkaff. The impact of cardiovascular drugs on hyperglycemia and diabetes: a review of ‘unspoken' side effects. Hellenic Journal of Cardiology 2025; 83 doi: 10.1016/j.hjc.2024.09.007
|
| 30 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2018; doi: 10.1007/978-3-319-44433-8_19
|
| 31 |
Rami Al Batran, Keshav Gopal, Hanin Aburasayn, Amina Eshreif, Malak Almutairi, Amanda A. Greenwell, Scott A. Campbell, Bruno Saleme, Emily A. Court, Farah Eaton, Peter E. Light, Gopinath Sutendra, John R. Ussher. The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity. JCI Insight 2019; 4(1) doi: 10.1172/jci.insight.124643
|
| 32 |
Mortaza Fatehi Hassanabad, Mohammad Fatehi. Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis. Current Diabetes Reviews 2019; 15(2) doi: 10.2174/1573399814666180424123912
|
| 33 |
Xiao Tan, Christian Benedict. Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication. BMJ Open Diabetes Research & Care 2020; 8(1) doi: 10.1136/bmjdrc-2020-001702
|
| 34 |
Marie-Anne Heurtebize, Jean-Luc Faillie. Drug-induced hyperglycemia and diabetes. Therapies 2024; 79(2) doi: 10.1016/j.therap.2023.09.010
|
| 35 |
Vivianne Presta, Ilaria Figliuzzi, Barbara Citoni, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci, Massimo Volpe. ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients. High Blood Pressure & Cardiovascular Prevention 2021; 28(3) doi: 10.1007/s40292-021-00443-z
|
| 36 |
Kazunori Shimada, Katsumi Miyauchi, Hiroyuki Daida. Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders. Expert Review of Cardiovascular Therapy 2015; 13(1) doi: 10.1586/14779072.2015.986464
|
| 37 |
Tamara Yakubov, Muhammad Abu Tailakh, Arthur Shiyovich, Harel Gilutz, Ygal Plakht. Incidence and Risk Factors for Developing Type 2 Diabetes Mellitus After Acute Myocardial Infarction—A Long-Term Follow-Up. Journal of Cardiovascular Development and Disease 2025; 12(3) doi: 10.3390/jcdd12030089
|
| 38 |
Briana J. Taylor, Karen A. Matthews, Brant P. Hasler, Kathryn A. Roecklein, Christopher E. Kline, Daniel J. Buysse, Howard M. Kravitz, Alaina G. Tiani, Sioban D. Harlow, Martica H. Hall. Bedtime Variability and Metabolic Health in Midlife Women: The SWAN Sleep Study. Sleep 2016; 39(2) doi: 10.5665/sleep.5464
|
| 39 |
Jovana Jeremic, Natalia Govoruskina, Jovana Bradic, Isidora Milosavljevic, Ivan Srejovic, Vladimir Zivkovic, Nevena Jeremic, Tamara Nikolic Turnic, Irena Tanaskovic, Stefani Bolevich, Vladimir Jakovljevic, Sergey Bolevich, Marko N. Zivanovic, Nduka Okwose, Dragana Seklic, Nevena Milivojevic, Jelena Grujic, Lazar Velicki, Guy MacGowan, Djordje G. Jakovljevic, Nenad Filipovic. Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathy. Molecular and Cellular Biochemistry 2023; 478(12) doi: 10.1007/s11010-023-04690-7
|
| 40 |
Prakhar Tyagi, Khushbu Jain. Effects of yogic practices on physiological and biochemical parameters of hypertensive patients: A systematic review of clinical trials. Journal of Ayurveda and Integrative Medicine 2025; 16(3) doi: 10.1016/j.jaim.2024.101087
|
| 41 |
Hatice Ozcaliskan Ilkay, Habibe Sahin, Fatih Tanriverdi, Gulhan Samur. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. Journal of the American College of Nutrition 2019; 38(1) doi: 10.1080/07315724.2018.1476194
|
| 42 |
Diego Soares Carvalho, Alexandre Aparecido de Almeida, Aurélio Ferreira Borges, Diego Vannucci Campos. Treatments for diabetes mellitus type II: New perspectives regarding the possible role of calcium and cAMP interaction. European Journal of Pharmacology 2018; 830 doi: 10.1016/j.ejphar.2018.04.002
|
| 43 |
Martha B. Ramírez-Rosas, Adriana L. Perales-Torres, Rubén Santiago-Adame. Ethnomedicinal Plant Use and Practice in Traditional Medicine. Advances in Medical Diagnosis, Treatment, and Care 2020; doi: 10.4018/978-1-7998-1320-0.ch006
|
| 44 |
Kahomi Sazawa, Kohei Ohno, Tomohisa Yamashita, Shoya Ino, Satoru Shibata, Takahito Itoh, Hiroyuki Hotta, Tomoaki Matsumoto, Hitoshi Ooiwa, Hirofumi Kubo, Takayuki Miki. Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension. Circulation Reports 2022; 4(12) doi: 10.1253/circrep.CR-22-0109
|
| 45 |
S-W Chang, C W McDonough, Y Gong, T A Johnson, T Tsunoda, E R Gamazon, M A Perera, A Takahashi, T Tanaka, M Kubo, C J Pepine, J A Johnson, R M Cooper-DeHoff. Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. The Pharmacogenomics Journal 2018; 18(1) doi: 10.1038/tpj.2016.67
|
| 46 |
Martha B. Ramírez-Rosas, Adriana L. Perales-Torres, Rubén Santiago-Adame. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals. 2022; doi: 10.4018/978-1-6684-3546-5.ch017
|
| 47 |
Gergely Fehér, Gabriella Pusch. Role of antihypertensive drugs in the treatment of migraine. Orvosi Hetilap 2015; 156(5) doi: 10.1556/OH.2015.30056
|
| 48 |
Débora Dias de Lucena, João Roberto de Sá, José O. Medina-Pestana, Érika Bevilaqua Rangel. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. Journal of Diabetes Research 2020; 2020 doi: 10.1155/2020/1938703
|
| 49 |
Mieczysław Litwin, Janusz Feber, Anna Niemirska, Jacek Michałkiewicz. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatric Nephrology 2016; 31(2) doi: 10.1007/s00467-015-3065-y
|
| 50 |
Icilma V. Fergus, Kenneth L. Connell, Keith C. Ferdinand. A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk. Current Cardiology Reports 2015; 17(6) doi: 10.1007/s11886-015-0592-x
|
| 51 |
Maria Greabu, Silviu Constantin Badoiu, Iulia-Ioana Stanescu-Spinu, Daniela Miricescu, Alexandra Ripszky Totan, Silvia Elena Badoiu, Michel Costagliola, Viorel Jinga. Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms22189782
|
| 52 |
Wilma S. Leslie, Eman Ali, Leanne Harris, C. Martina Messow, Naomi T. Brosnahan, George Thom, E. Louise McCombie, Alison C. Barnes, Naveed Sattar, Roy Taylor, Michael E. J. Lean. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia 2021; 64(9) doi: 10.1007/s00125-021-05471-x
|
| 53 |
Akshay B. Jain, Valerie Lai. Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies. Diabetes Therapy 2024; 15(9) doi: 10.1007/s13300-024-01628-0
|
| 54 |
Elizabeth Black, Jason Lee, Joseph T. Flynn, Charles E. McCulloch, Joshua A. Samuels, Divya Seth, Bradley Warady, Susan Furth, Mark Mitsnefes, Elaine Ku. Discordances between pediatric and adult thresholds in the diagnosis of hypertension in adolescents with CKD. Pediatric Nephrology 2022; 37(1) doi: 10.1007/s00467-021-05166-w
|
| 55 |
Jin Wook Lee, Hyun-Oh Gu, Yunshin Jung, YunJae Jung, Seung-Yong Seo, Jeong-Hee Hong, In-Sun Hong, Dae Ho Lee, Ok-Hee Kim, Byung-Chul Oh. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation. Experimental & Molecular Medicine 2023; 55(5) doi: 10.1038/s12276-023-00982-6
|
| 56 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2019; doi: 10.1007/978-3-319-27316-7_19-2
|
| 57 |
Ye Seul Yang, Min Hyuk Lim, Seong Ok Lee, Eun Roh, Chang Ho Ahn, Soo Heon Kwak, Young Min Cho, Sungwan Kim, Andrea Mari, Kyong Soo Park, Hye Seung Jung. Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. Diabetes, Obesity and Metabolism 2018; 20(7) doi: 10.1111/dom.13282
|
| 58 |
O. A. Polyakova, O. D. Ostroumova. Features of management of patients with cardiometabolic polymorbidity phenotype: focus on the efficacy and safety of bisoprolol. Meditsinskiy sovet = Medical Council 2023; (16) doi: 10.21518/ms2023-220
|
| 59 |
Mustafa Tosur, Johanna Viau-Colindres, Marcela Astudillo, Maria Jose Redondo, Sarah K Lyons. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Research & Care 2020; 8(1) doi: 10.1136/bmjdrc-2019-000801
|
| 60 |
Yang Zhao, Qiongying Wang, Xu Zhao, Huitao Meng, Jing Yu. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies. Clinical and Experimental Hypertension 2018; 40(1) doi: 10.1080/10641963.2017.1288736
|
| 61 |
Diego Castro Musial, Regiane Miranda‐Ferreira, Juan Fernando Padin, Juan Alberto Arranz‐Tagarro, Alberto J. Parra‐Vitela, Aron Jurkiewicz, Antonio Garcia Garcia, Neide Hyppolito Jurkiewicz. Function of AT1 and AT2 receptors in atrial contractions from spontaneous hypertensive and diabetic‐induced streptozotocin rats. Clinical and Experimental Pharmacology and Physiology 2018; 45(12) doi: 10.1111/1440-1681.13019
|
| 62 |
Simona Frontoni, Fabiana Picconi. Diabetes Complications, Comorbidities and Related Disorders. Endocrinology 2020; doi: 10.1007/978-3-030-36694-0_19
|
| 63 |
Ghada M. Ahmed, Mohammed N. Abed, Fawaz A. Alassaf. Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3) doi: 10.1007/s00210-023-02731-y
|
| 64 |
Saqib S Aufi, Mohammad W Hussain. Efficacy of Empagliflozin–Linagliptin Combination Therapy in Managing Uncontrolled Type 2 Diabetes Mellitus: A Quasi-experimental Study. Journal of Diabetes and Endocrine Clinics 2025; 1(1) doi: 10.5005/jodec-11035-0003
|
| 65 |
Renata Maksoud Bussuan, Ângela Cristine Bersch-Ferreira, Aline Marcadenti. Association between the number of glucose-lowering drugs in use, diet quality, and nutrient intake among adults with type 2 diabetes mellitus. Nutrition and Health 2025; 31(4) doi: 10.1177/02601060241303629
|
| 66 |
Neila Fathallah, Raoudha Slim, Sofien Larif, Houssem Hmouda, Chaker Ben Salem. Drug-Induced Hyperglycaemia and Diabetes. Drug Safety 2015; 38(12) doi: 10.1007/s40264-015-0339-z
|
| 67 |
Diana Jiménez-Rodríguez, Manuela Conesa-Garcerán, Teresa Belmonte-García. Evaluación del efecto de la terapia de relajación en pacientes con hipertensión arterial. Enfermería Clínica 2019; 29(3) doi: 10.1016/j.enfcli.2018.07.005
|